ID: ALA4741002

Max Phase: Preclinical

Molecular Formula: C56H74N10O7

Molecular Weight: 999.27

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  C=CC(=O)Nc1cccc(-n2c(=O)cc(C)c3cnc(Nc4ccc(N5CCN(C(=O)CCCCCCCCCCCNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](O)[C@H](N)Cc6ccccc6)CC5)cc4OC)nc32)c1

Standard InChI:  InChI=1S/C56H74N10O7/c1-6-49(67)60-41-22-19-23-43(35-41)66-51(69)33-39(4)44-37-59-56(63-53(44)66)62-46-26-25-42(36-48(46)73-5)64-28-30-65(31-29-64)50(68)24-17-12-10-8-7-9-11-13-18-27-58-54(71)47(32-38(2)3)61-55(72)52(70)45(57)34-40-20-15-14-16-21-40/h6,14-16,19-23,25-26,33,35-38,45,47,52,70H,1,7-13,17-18,24,27-32,34,57H2,2-5H3,(H,58,71)(H,60,67)(H,61,72)(H,59,62,63)/t45-,47+,52+/m1/s1

Standard InChI Key:  DOEISPNISSZUOZ-KTBSTWIUSA-N

Associated Targets(Human)

EGFR Tclin Baculoviral IAP repeat-containing protein 2/Epidermal growth factor receptor (1 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 999.27Molecular Weight (Monoisotopic): 998.5742AlogP: 7.09#Rotatable Bonds: 27
Polar Surface Area: 226.14Molecular Species: NEUTRALHBA: 13HBD: 6
#RO5 Violations: 4HBA (Lipinski): 17HBD (Lipinski): 7#RO5 Violations (Lipinski): 4
CX Acidic pKa: 12.32CX Basic pKa: 8.35CX LogP: 7.59CX LogD: 6.60
Aromatic Rings: 5Heavy Atoms: 73QED Weighted: 0.02Np Likeness Score: -0.74

References

1. Zhang X,Xu F,Tong L,Zhang T,Xie H,Lu X,Ren X,Ding K.  (2020)  Design and synthesis of selective degraders of EGFR mutant.,  192  [PMID:32171162] [10.1016/j.ejmech.2020.112199]

Source